⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HAE

Haemonetics Corporation

Healthcare · Medical Devices

118.51USD

+2.3500 (+2.02%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on HAE.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End03/2026
Last Quarter End06/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 118.51
P/E56.0
Dvd Ind Yld0.0%
P/B6.44
P/S4.0
Curr EV/T12M EBITDA23.5
Mkt Cap (USD)5.4B
Curr EV (USD)6.3B
2)

Per Share Data

EPS T12M2.05
DPS—
Bk Val Per Sh18.41
Rev/Sh29.58
Cash/Sh4.94
Curr Shares Out45.5M
FCF/Sh6.37
3)

Cash Flow Analysis

P/CF16.4
Curr P/FCF18.5
CF/NI3.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales24.3%
Eff Interest Rate1.6%
4)

Growth Potential

Dil EPS 1Y Gr-38.1%
Cap 1Y Gr-1.2%
BPS 1Y Gr3.9%
R&D To Sales4.4%
Retention Rate100.0%
Rev 1Y Gr-2.0%
FCF 1Y Gr82.8%
Assets 1Y Gr-2.2%
5)

Profitability

EBITDA0.3B
EBIT0.2B
Operating Margin11.9%
Pretax Margin9.6%
Net Margin7.1%
ROA4.0%
ROE11.2%
ROC5.9%
Asset Turnover0.56
6)

Structure

Current Ratio3.08
Quick Ratio1.67
Debt/Assets49.6%
Debt/Com Eq140.3%
Net Debt/EBITDA3.52
Tot Debt/Capital58.4%
Gross Margin59.0%
EBIT/Int Exp8.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.